Silk Road Medical, Inc (SILK)
27.49
0.00 (0.00%)
Inactive · Last trade price on Sep 17, 2024
Silk Road Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 191.43 | 177.13 | 138.64 | 101.48 | 75.23 | 63.35 |
Revenue Growth | 17.53% | 27.77% | 36.62% | 34.89% | 18.74% | 83.33% |
Gross Profit Gross Profit Growth | 142.19 | 127.09 | 100.76 | 76.03 | 53.94 | 47.43 |
Operating Income Operating Income Growth | -60.17 | -59.27 | -52 | -47.47 | -42.86 | -28.07 |
Net Income Net Income Growth | -56.54 | -55.74 | -55.01 | -49.81 | -47.37 | -52.42 |
Earnings Per Share EPS Growth | -1.44 | -1.44 | -1.54 | -1.44 | -1.44 | -2.28 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 171.98 | 181.47 | 213.67 | 110.23 | 147.48 | 90.69 |
Total Debt Total Debt Growth | 84.47 | 84.63 | 82.44 | 55.73 | 52.23 | 49.35 |
Net Cash (Debt) Net Cash Growth | 87.52 | 96.84 | 131.24 | 54.5 | 95.25 | 41.34 |
Net Cash Growth | -15.53% | -26.21% | 140.80% | -42.78% | 130.40% | - |
Net Cash Per Share Net Cash Per Share Growth | 2.23 | 2.50 | 3.67 | 1.57 | 2.89 | 1.80 |
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -33.96 | -32.01 | -32.58 | -38.94 | -42.07 | -29.61 |
Capital Expenditures CapEx Growth | -2.13 | -1.51 | -5.01 | -4.76 | -0.84 | -0.54 |
Free Cash Flow Free Cash Flow Growth | -36.08 | -33.52 | -37.59 | -43.69 | -42.91 | -30.15 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | 74.28% | 71.75% | 72.68% | 74.92% | 71.70% | 74.86% |
Operating Margin | -31.43% | -33.46% | -37.51% | -46.78% | -56.97% | -44.30% |
Pretax Margin | -29.51% | -31.45% | -39.66% | -49.07% | -62.95% | -82.72% |
Profit Margin | -29.53% | -31.47% | -39.68% | -49.09% | -62.96% | -82.73% |
FCF Margin | -18.85% | -18.92% | -27.11% | -43.06% | -57.04% | -47.58% |
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 30, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PS Ratio | 5.63 | 2.70 | 14.53 | 14.65 | 28.43 | 19.67 |